Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

Prism’s peptide mimetic platform finds second discovery partner

June 11, 2020 11:44 PM UTC

Prism has closed a deal with its second large pharma partner, agreeing to collaborate with Boehringer to discover multiple compounds using its peptide mimetic platform.

Financial terms and therapeutic focus of Monday’s deal are undisclosed. Prism BioLab Co. Ltd. will screen its library of peptide mimetic small molecules against targets chosen by Boehringer Ingelheim GmbH, which has options to license and develop any resulting compounds...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article